Pailin Biotech: Announcement on Change of Signing Certified Public Accountant
Securities code: 000403 Securities abbreviation: Pais Shuanglin Biotech Announcement number: 2026-011 Pais Shuanglin Biopharmaceutical Co., Ltd.
Announcement on Change of Signing Certified Public Accountant
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
Pais Shuanglin Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 17th meeting of the 10th Board of Directors and the 2025 second extraordinary general meeting of shareholders on August 20, 2025 and September 8, 2025 respectively, and reviewed and approved the "Proposal on the Renewal of the Company's Audit Institution in 2025" and agreed to renew the appointment of KPMG Huazhen Accounting Firm (Special General Partnership) (hereinafter) (referred to as "KPMG Huazhen") is the company's 2025 financial report and internal control audit agency. For details, please refer to the "Announcement on the Re-appointment of the Audit Agency for 2025" (Announcement Number: 2025-038) disclosed by the company on August 22, 2025 in the Securities Times, Shanghai Securities News and Juchao Information Network (www.cninfo.com.cn).
The company disclosed the "Announcement on the Change of Signing Certified Public Accountants" (Announcement No.: 2025-050) on the Securities Times, Shanghai Securities News and Juchao Information Network (www.cninfo.com.cn) on October 29, 2025. Due to adjustments in work arrangements, the signing certified public accountants assigned by KPMG Huazhen for the company's 2025 audit project were changed from Ms. Zhang Yang and Wang Pu to Ms. Wang Pu and Li Bingman.
Recently, the company received the "Letter Regarding Change of Certified Public Accountant for the 2025 Audit Signature of Pais Shuanglin Biopharmaceutical Co., Ltd." issued by KPMG Huazhen. The relevant information is now announced as follows:
1. Basic information on changing the signing accountant
KPMG Huazhen originally assigned Ms. Wang Pu and Ms. Li Bingman as the signing certified public accountants for the company’s 2025 audit project. In view of the resignation of the original signing CPA, Ms. Li Bingman, Ms. Wang Pu and Zhang Xuedan are now assigned as the signing CPAs for this project to continue to complete the company's 2025 financial report and internal control audit related work. After this change, the signing certified public accountants for the company's 2025 financial report audit and internal control audit are Ms. Wang Pu and Zhang Xuedan, and the quality control reviewer is Mr. Luo Ke.
2. Information of the signing accountant for this change
- Basic information
Ms. Zhang Xuedan joined KPMG Huazhen in 2017 and began to engage in auditing of listed companies and professional services related to capital markets. She became a Chinese Certified Public Accountant in November 2021 and is currently a practicing member of the Chinese Certified Public Accountants. Ms. Zhang Xuedan began to provide audit services for the company in 2024 and served as the company's audit service project manager. She has not signed or reviewed the audit report of a listed company in the past three years.
- Independence and integrity
In the past three years, Ms. Zhang Xuedan has not been subject to criminal penalties for her professional conduct, administrative penalties, supervisory and management measures from the China Securities Regulatory Commission and its dispatched agencies, and industry authorities, and self-regulatory measures and disciplinary sanctions from self-regulatory organizations such as securities trading venues and industry associations.
3. Other situation descriptions
Relevant work arrangements during this change have been handed over in an orderly manner, and this change will not have an adverse impact on the company's 2025 audit work.
4. Documents for reference
- "Letter from KPMG Huazhen Accounting Firm (Special General Partnership) Regarding the Change of the Signing Certified Public Accountant for the 2025 Audit of Pais Shuanglin Biopharmaceutical Co., Ltd."
Announcement is hereby made.
Pais Shuanglin Biopharmaceutical Co., Ltd.
board of directors
March 18, 2026